Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000911916-15-000316
Filing Date
2015-08-25
Accepted
2015-08-25 15:10:22
Documents
1
Period of Report
2015-08-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3553
  Complete submission text file 0000911916-15-000316.txt   4943
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Issuer) CIK: 0001348649 (see all company filings)

EIN.: 203419541 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Mathers Thomas P. (Reporting) CIK: 0001639978 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37358 | Film No.: 151072984